In conclusion, our study advanced the general understanding of the role of TNFR2 signaling in regulating microglial responses after IS and SCI, setting the stage for novel therapeutic approaches to tackle these invalidating neurological diseases. This evidence concerns the gene TNFRSF1B and nervous system disorder.